Yahoo Web Search

Search results

    • 2 Stocks That Could 10x by 2035

      2 Stocks That Could 10x by 2035

      Motley Fool via Yahoo Finance· 6 hours ago

      In this sense, Recursion Pharmaceuticals is as much a tech company as a biotech. If the company is successful, it would be a significant paradigm shift...

    • Better Buy: Inovio Pharmaceuticals vs. Novavax

      Better Buy: Inovio Pharmaceuticals vs. Novavax

      Motley Fool via Yahoo Finance· 2 days ago

      s why Novavax is a better bet among these two companies, even though its market capitalization is much higher at $1.87 billion. With that said, Novavax...

    • Is It Too Late to Buy Viking Therapeutics Stock?

      The Motley Fool via AOL· 2 days ago

      According to Vantage Market Research, the global market for obesity interventions will be worth nearly $39 billion by 2030. The business only needs to capture a small slice ...